SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

Summary

SU5416 may stop the growth of malignant melanoma by stopping blood flow to the tumor. Phase II trial to study the effectiveness of SU5416 in treating patients who have metastatic melanoma that has been previously treated

Timeline

Start

2000-07

Primary completion

2003-07

Completion

—

Drugs

Indications